8.75p+0.41 (+4.92%)14 May 2024, 15:37
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Intelligent Ultrasound Group PLC Fundamentals

Company NameIntelligent Ultrasound Group PLCLast Updated2024-05-14
IndustryMedical DevicesSectorHealthcare
Shares in Issue326.870 mMarket Cap£28.60 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.01EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0394Debt Equity Ratio0.0355
Asset Equity Ratio1.3455Cash Equity Ratio0.3028
Quick Ratio2.2686Current Ratio3.18
Price To Book Value2.8003ROCE0

Intelligent Ultrasound Group PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Intelligent Ultrasound Group PLC Company Financials

Assets20222021
Tangible Assets£1.17 m£1.40 m
Intangible Assets£3.27 m£2.56 m
Investments00
Total Fixed Assets£4.51 m£4.02 m
Stocks£1.60 m£1.20 m
Debtors£1.43 m£1.95 m
Cash & Equivalents£7.17 m£4.95 m
Other Assets£61,000.00£61,000.00
Total Assets£16.01 m£13.77 m
Liabilities20222021
Creditors within 1 year£3.28 m£3.21 m
Creditors after 1 year£572,000.00£842,000.00
Other Liabilities00
Total Liabilities£3.85 m£4.05 m
Net assets£12.16 m£9.72 m
Equity20222021
Called up share capital£3.27 m£2.71 m
Share Premium£30.21 m£25.96 m
Profit / Loss-£3.70 m-£4.37 m
Other Equity£12.16 m£9.72 m
Preference & Minorities00
Total Capital Employed£12.16 m£9.72 m
Ratios20222021
Debt Ratio£0.02£0.04
Debt-to-Equity£0.02£0.05
Assets / Equity1.34551.3455
Cash / Equity0.30280.3028
EPS-£0.01-£0.01
Cash Flow20222021
Cash from operating activities-£684,000.00-£1.82 m
Cashflow before financing£3.86 m-£2.04 m
Increase in Cash£2.04 m-£3.81 m
Income20222021
Turnover£10.10 m£7.60 m
Cost of sales£3.77 m£2.94 m
Gross Profit£6.33 m£4.66 m
Operating Profit£3.67 m£4.33 m
Pre-Tax profit-£3.70 m-£4.37 m

Intelligent Ultrasound Group PLC Company Background

SectorHealthcare
ActivitiesIntelligent Ultrasound Group PLC is engaged in the development, marketing, and distribution of ultrasound simulation devices for use in the training of medical professionals. Its product categories ScanTrainer; HeartWorks; BodyWorks; and ORSIM Bronchoscopy Simulator. The Company has two reportable segments such as Simulation which involves sales of ultrasound simulation systems and related services , Clinical AI which is involved in sales of AI-related ultrasound image analysis software products. The company earns majority of its revenue from Simulation segment . Geographically, it has a presence in the United Kingdom, North America, and the Rest of the World. It derives most of its revenue from the Rest of the World.
Latest Interim Date17 Aug 2023
Latest Fiscal Year End Date1 May 2024

Intelligent Ultrasound Group PLC Directors

AppointedNamePosition
2023-05-26Mr. Riccardo PigliucciNon-Executive Director,Chairman
2022-05-30Mr. David Graham BaynesNon-Executive Director
2023-12-22Mr. Stuart Arthur GallExecutive Director,Chief Executive Officer
2021-05-28Mr. Wilson Whitehead JenningsExecutive Director,Finance Director and Company Secretary
2023-12-22Mr. Nicholas James SleepExecutive Director,Chief Technology Officer
2022-05-30Professor Nazar Najib AmsoNon-Executive Director
2023-05-26Professor Nicholas John AvisNon-Executive Director
2023-05-26Ms. Ingeborg Dybdal OieNon-Executive Director
2023-12-28Mr. Ian George WhittakerExecutive Director,Chief Operating Officer
2023-05-26Mr. Andrew Charles Barker Non-Executive Director
2023-12-22Ms. Helen Mary Kinsey JonesExecutive Director,Chief Financial Officer

Intelligent Ultrasound Group PLC Contact Details

Company NameIntelligent Ultrasound Group PLC
AddressThe Cardiff Medicentre, Heath Park, Wales, CF14 4UJ
Telephone+44 2920756534
Websitehttps://www.intelligentultrasound.com

Intelligent Ultrasound Group PLC Advisors

Financial PR AdviserWalbrook PR
Phone+44 2079338780
Fax+44 2079338781
AuditorBDO LLP
StockbrokerCenkos Securities
Phone+44 2073978900
Fax+44 2073978901
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
SolicitorMemery Crystal
Phone+44 2072425905
Fax+44 2072422058
Nominated AdviserCenkos Securities
Phone+44 2073978900
Fax+44 2073978901